Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia and Development of Artificial Intelligence Modelling

September 26, 2023 updated by: Dr.dr.Irma Bernadette, SpKK (K)

Mapping of Indonesians' Skin Type Based on Baumann Skin Type Indicator-Indonesia (BSTI-Ina) Questionnaire and Development of Artificial Intelligence Modelling BSTI-Ina: A Multicentric Study

The goal of this observational study is to learn about the skin type of Indonesians based on Baumann Skin Type Indicator Questionnaire in Indonesian language version, and to develop artificial intelligence modelling of BSTI-Ina. The main questions it aims to answer are:

  1. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2006 version which was adapted from BSTI questionnaire in English language year 2006 version as a specific measurement to identify skin type?
  2. What is the measurement of the validity and reliability of BSTI-Ina questionnaire year 2022 version which was adapted from BSTI questionnaire in English language year 2022 version as a specific measurement to identify skin type?
  3. What is the comparison of the validity and reliability between BSTI-Ina questionnaire year 2006 and year 2022 to determine Indonesian adult population's skin type?
  4. How is the mapping of Indonesians' skin type based on BSTI-Ina?
  5. What is the proportion of each skin type based on BSTI-Ina in Indonesian population?
  6. What is the proportion of each skin type based on BSTI-Ina in Indonesian population sociodemographically?
  7. How can Artificial Intelligence help categorize skin type based on BSTI-Ina automatically?

Participants are males and females between 18-59 year old. Participants will be asked to fill BSTI-Ina questionnaire. Participants then will be photographed in five different positions.

Study Overview

Status

Active, not recruiting

Detailed Description

This research is an observational study with a cross-sectional design. The aims of this study is to determine the validity and reliability of BSTI questionnaire translated in Indonesian and to develop artificial intelligence modelling for BSTI-Ina based on photographs. This study will be held in 13 research centers with a total of 1950 subjects consists of males and females age 18-59. It conducts of 2 phases. Phase 1 is to determine which version of BSTI will be used based on which one is more valid and reliable being translated in Indonesian and will be conducted in Jakarta as a pilot. In phase 1, participants will be asked to fill both BSTI-Ina 2006 and 2002 questionnaire. Participants then will be photographed in five different positions. Data will be analyzed to determine which of BSTI-Ina version is more valid and reliable. After deciding which BSTI-Ina version will be used, the study then goes to phase 2. Phase 2 will be conducted in 12 other research centers in Indonesia to map Indonesian population skin type. In both 2 phases, all participants will be asked to fill in BSTI-Ina questionnaire (either 2006 or 2022 version based on the result of Phase 1). Participants then will be photographed in five different positions. After all the data from all research centers are collected, data will be analyzed to map Indonesian population's skin type. Data as participants' skin types and photographs will also be processed by machine to model artificial intelligence. The aim is to automatically categorize skin type based on BSTI-Ina based on photographs.

Study Type

Observational

Enrollment (Estimated)

1950

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Bali
      • Denpasar, Bali, Indonesia, 80113
        • Rumah Sakit Umum Pusat Prof. Dr. I Goesti Ngoerah Gde Ngoerah
        • Contact:
          • I Gusti Ayu A Praharsini, MD
          • Phone Number: +628123888794
    • Central Java
      • Semarang, Central Java, Indonesia, 50244
        • Rumah Sakit Umum Pusat Dr. Kariadi
        • Contact:
          • Puguh Riyanto, MD
          • Phone Number: +628113319892
      • Surakarta, Central Java, Indonesia, 57126
        • Rumah Sakit Umum Daerah Dr. Moewardi
        • Contact:
          • Arie Kusumawardani, MD
          • Phone Number: +628122840012
    • DKI Jakarta
      • Jakarta Pusat, DKI Jakarta, Indonesia, 10430
        • Rumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo
        • Principal Investigator:
          • Irma BS Sitohang, MD
        • Sub-Investigator:
          • Hanny Nilasari, MD
        • Sub-Investigator:
          • Sandra Widaty, MD
        • Sub-Investigator:
          • Irwan Batubara, MD
        • Contact:
    • East Java
      • Malang, East Java, Indonesia, 65112
        • Rumah Sakit Umum Daerah Dr. Saiful Anwar
        • Contact:
          • Shinta Murlistyarini, MD
          • Phone Number: +6281325466699
      • Surabaya, East Java, Indonesia, 60286
        • Rumah Sakit Umum Daerah Dr. Soetomo
        • Contact:
          • Diah M Indramaya, MD
          • Phone Number: +628123037841
    • North Sulawesi
      • Manado, North Sulawesi, Indonesia, 95262
        • Rumah Sakit Umum Pusat Prof. dr. R. D. Kandou
        • Contact:
          • Marlyn G Kapantow, MD
          • Phone Number: +628124302030
    • North Sumatra
      • Medan, North Sumatra, Indonesia, 20154
        • Rumah Sakit Universitas Sumatera Utara
        • Contact:
          • Nelva K Jusuf, MD
          • Phone Number: +62811651432
    • South Sulawesi
      • Makassar, South Sulawesi, Indonesia, 90245
        • Rumah Sakit Umum Pusat Dr. dr. Wahidin Sudirohusodo
        • Contact:
          • Asnawi Madjid, MD
          • Phone Number: +6281342765752
    • South Sumatra
      • Palembang, South Sumatra, Indonesia, 30126
        • Rumah Sakit Umum Pusat Dr. Mohammad Hoesin
        • Contact:
          • Yuli Kurniawati, MD
          • Phone Number: +628127150511
    • Special Region Of Yogyakarta
      • Yogyakarta, Special Region Of Yogyakarta, Indonesia, 55281
        • Rumah Sakit Umum Pusat Dr. Sardjito
        • Contact:
          • Flandiana Yogianti, MD
          • Phone Number: +6282138470777
    • West Java
      • Bandung, West Java, Indonesia, 40161
        • Rumah Sakit Umum Pusat Dr. Hasan Sadikin
        • Contact:
          • Reti Hindritiani, MD
          • Phone Number: +628156022505
    • West Sumatra
      • Padang, West Sumatra, Indonesia, 25171
        • Rumah Sakit Umum Pusat Dr. M. Djamil
        • Contact:
          • Satya W Yenny, MD
          • Phone Number: +628126617869

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

General adult population

Description

Inclusion Criteria:

  • Males and females age 18-59 year old.
  • Fitzpatrick's skin type III-V
  • Educational degree of minimum high school
  • Can speak Indonesian
  • Can read
  • Willing to participate and sign informed consent

Exclusion Criteria:

  • Participant who doesn't fill the questionnaire completely
  • Participant with skin disease involving >25% facial area

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
General
This research is an observational study. There's no control and experimental group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Baumann Skin Type Indicator questionnaire 2006 version in Indonesian language
Time Frame: Up to 2 weeks
Adapting Baumann Skin Type Indicator questionnaire 2006 version to Baumann Skin Type Indicator questionnaire 2006 version in Indonesian language by certified translators
Up to 2 weeks
Baumann Skin Type Indicator questionnaire 2022 version in Indonesian language
Time Frame: Up to 2 weeks
Adapting Baumann Skin Type Indicator questionnaire 2022 version to Baumann Skin Type Indicator questionnaire 2022 version in Indonesian language by certified translators
Up to 2 weeks
More valid and reliable version of Baumann Skin Type Indicator-Ina questionnaire (2006 or 2022 version)
Time Frame: Up to 1 month
Comparing between Baumann Skin Type Indicator-Ina questionnaire 2006 version and 2022 version by statistician
Up to 1 month
Mapping of Indonesian population's skin type based on Baumann Skin Type Indicator-Ina
Time Frame: Up to 2 months
Determine the proportion of Indonesia population's skin type based on Baumann Skin Type Indicator in 13 research centers
Up to 2 months
Capability of artificial intelligence model to categorize skin type based on Baumann Skin Type Indicator-Ina
Time Frame: Up to 1 month
Data such as participants' skin types and photographs will be analyzed by machine resulting AI to categorize skin type automatically by photographs.
Up to 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Irma Bernadette, MD, Faculty of medicine, University of Indonesia
  • Study Director: Hanny Nilasari, MD, Faculty of medicine, University of Indonesia
  • Study Director: Sandra Widaty, MD, Faculty of medicine, University of Indonesia
  • Study Director: Nelva K Jusuf, MD, Faculty of Medicine, University of North Sumatra
  • Study Director: Puguh Riyanto, MD, Faculty of Medicine, Diponegoro University
  • Study Director: Asnawi Madjid, MD, Faculty of Medicine, Hasanuddin University
  • Study Director: Marlyn G Kapantow, MD, Faculty of Medicine, Sam Ratulangi University
  • Study Director: I Gusti Ayu A Praharsini, MD, Faculty of Medicine, Udayana University
  • Study Director: Reti Hindritiani, MD, Faculty of Medicine, Padjadjaran University
  • Study Director: Diah M Indramaya, MD, Faculty of Medicine, Airlangga University
  • Study Director: Yuli Kurniawati, MD, Faculty of Medicine, Sriwijaya University
  • Study Director: Satya W Yenny, MD, Faculty of Medicine, Andalas University
  • Study Director: Arie Kusumawardani, MD, Faculty of Medicine, Sebelas Maret University
  • Study Director: Shinta Murlistyarini, MD, Faculty of Medicine, Brawijaya University
  • Study Director: Flandiana Yogianti, MD, Faculty of Medicine, Gadjah Mada University
  • Study Director: Aria Kekalih, MD, Faculty of medicine, University of Indonesia
  • Study Director: Prasandhya A Yusuf, PhD, Indonesia Medical Education and Research Institute, University of Indonesia
  • Study Director: Eric D Tenda, MD, Indonesia Medical Education and Research Institute, University of Indonesia
  • Study Director: Vanya V Valindria, PhD, Indonesia Medical Education and Research Institute, University of Indonesia
  • Study Director: Sari Chairunnisa, MD, Paragon Technology & Innovation
  • Study Director: Irwan Batubara, MD, Faculty of medicine, University of Indonesia

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 8, 2023

Primary Completion (Estimated)

November 1, 2023

Study Completion (Estimated)

December 1, 2023

Study Registration Dates

First Submitted

April 5, 2023

First Submitted That Met QC Criteria

May 3, 2023

First Posted (Actual)

May 6, 2023

Study Record Updates

Last Update Posted (Actual)

September 28, 2023

Last Update Submitted That Met QC Criteria

September 26, 2023

Last Verified

September 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • MappingofBSTI

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Baumann Skin Type Indicator

3
Subscribe